Yunnan Baiyao Group Co Ltd Asset Resilience Ratio

Latest as of September 2025: 8.38%

Yunnan Baiyao Group Co Ltd asset resilience ratio. Yunnan Baiyao Group Co Ltd (000538) has an Asset Resilience Ratio of 8.38% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 000538 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥4.47 Billion
≈ $654.02 Million USD Cash + Short-term Investments

Total Assets

CN¥53.34 Billion
≈ $7.81 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Yunnan Baiyao Group Co Ltd (1993–2024)

Asset resilience ratio of Yunnan Baiyao Group Co Ltd from 1993 to 2024. This chart shows how Yunnan Baiyao Group Co Ltd's Asset Resilience Ratio has changed over time. Read Yunnan Baiyao Group Co Ltd (000538) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Yunnan Baiyao Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 000538 asset base.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥4.47 Billion 8.38%
Total Liquid Assets CN¥4.47 Billion 8.38%

Asset Resilience Insights

  • Limited Liquidity: Yunnan Baiyao Group Co Ltd maintains only 8.38% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Yunnan Baiyao Group Co Ltd Industry Peers by Asset Resilience Ratio

Compare Yunnan Baiyao Group Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Galderma Group N
SW:GALD
Drug Manufacturers - Specialty & Generic 3.56%
Enzymatica publ AB
ST:ENZY
Drug Manufacturers - Specialty & Generic 22.17%
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
Drug Manufacturers - Specialty & Generic 9.04%
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
Drug Manufacturers - Specialty & Generic 47.16%
Kangmei Pharmaceutical Co Ltd
SHG:600518
Drug Manufacturers - Specialty & Generic 0.00%
Walvax BioTech
SHE:300142
Drug Manufacturers - Specialty & Generic 2.20%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%

Yunnan Baiyao Group Co Ltd Asset Resilience Ratio by Year (1993–2024)

Yunnan Baiyao Group Co Ltd asset resilience ratio by year from 1993 to 2024. The table below shows the annual Asset Resilience Ratio data for Yunnan Baiyao Group Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 4.81% CN¥2.55 Billion
≈ $372.72 Million
CN¥52.91 Billion
≈ $7.74 Billion
+4.54pp
2023-12-31 0.28% CN¥149.37 Million
≈ $21.86 Million
CN¥53.78 Billion
≈ $7.87 Billion
-4.25pp
2022-12-31 4.53% CN¥2.42 Billion
≈ $353.50 Million
CN¥53.32 Billion
≈ $7.80 Billion
-4.50pp
2021-12-31 9.03% CN¥4.72 Billion
≈ $690.71 Million
CN¥52.29 Billion
≈ $7.65 Billion
-11.31pp
2020-12-31 20.33% CN¥11.23 Billion
≈ $1.64 Billion
CN¥55.22 Billion
≈ $8.08 Billion
+2.57pp
2019-12-31 17.76% CN¥8.82 Billion
≈ $1.29 Billion
CN¥49.66 Billion
≈ $7.27 Billion
-6.15pp
2018-12-31 23.92% CN¥7.26 Billion
≈ $1.06 Billion
CN¥30.38 Billion
≈ $4.45 Billion
-0.45pp
2017-12-31 24.36% CN¥6.75 Billion
≈ $987.65 Million
CN¥27.70 Billion
≈ $4.05 Billion
+16.22pp
2016-12-31 8.14% CN¥2.00 Billion
≈ $293.00 Million
CN¥24.59 Billion
≈ $3.60 Billion
-7.62pp
2015-12-31 15.77% CN¥3.04 Billion
≈ $445.07 Million
CN¥19.29 Billion
≈ $2.82 Billion
+13.10pp
2014-12-31 2.67% CN¥436.37 Million
≈ $63.85 Million
CN¥16.34 Billion
≈ $2.39 Billion
+2.67pp
2013-12-31 0.00% CN¥149.76K
≈ $21.91K
CN¥12.88 Billion
≈ $1.88 Billion
0.00pp
2011-12-31 0.01% CN¥519.68K
≈ $76.05K
CN¥9.09 Billion
≈ $1.33 Billion
-0.02pp
2006-12-31 0.03% CN¥587.23K
≈ $85.93K
CN¥2.19 Billion
≈ $320.67 Million
+0.01pp
2005-12-31 0.01% CN¥239.41K
≈ $35.03K
CN¥1.60 Billion
≈ $234.20 Million
-0.08pp
2004-12-31 0.09% CN¥1.19 Million
≈ $174.33K
CN¥1.27 Billion
≈ $185.96 Million
+0.07pp
2003-12-31 0.02% CN¥248.88K
≈ $36.42K
CN¥1.05 Billion
≈ $153.02 Million
-0.01pp
2002-12-31 0.03% CN¥306.44K
≈ $44.84K
CN¥920.65 Million
≈ $134.72 Million
-0.02pp
2001-12-31 0.05% CN¥416.78K
≈ $60.99K
CN¥843.99 Million
≈ $123.50 Million
-0.77pp
2000-12-31 0.82% CN¥6.53 Million
≈ $955.00K
CN¥792.85 Million
≈ $116.02 Million
+0.66pp
1999-12-31 0.16% CN¥1.25 Million
≈ $183.46K
CN¥761.62 Million
≈ $111.45 Million
-0.71pp
1998-12-31 0.88% CN¥3.09 Million
≈ $452.77K
CN¥351.99 Million
≈ $51.51 Million
+0.70pp
1997-12-31 0.18% CN¥565.84K
≈ $82.80K
CN¥315.44 Million
≈ $46.16 Million
-7.32pp
1996-12-31 7.50% CN¥19.45 Million
≈ $2.85 Million
CN¥259.26 Million
≈ $37.94 Million
-19.63pp
1995-12-31 27.14% CN¥66.80 Million
≈ $9.77 Million
CN¥246.17 Million
≈ $36.02 Million
-2.89pp
1994-12-31 30.03% CN¥60.30 Million
≈ $8.82 Million
CN¥200.83 Million
≈ $29.39 Million
+16.98pp
1993-12-31 13.05% CN¥23.00 Million
≈ $3.37 Million
CN¥176.27 Million
≈ $25.79 Million
--
pp = percentage points

About Yunnan Baiyao Group Co Ltd

SHE:000538 China Drug Manufacturers - Specialty & Generic
Market Cap
$14.02 Billion
CN¥95.83 Billion CNY
Market Cap Rank
#1666 Global
#130 in China
Share Price
CN¥53.71
Change (1 day)
+1.47%
52-Week Range
CN¥47.00 - CN¥57.39
All Time High
CN¥15689.57
About

Yunnan Baiyao Group Co.,Ltd engages in the pharmaceutical business in China. The company offers health products; drugs; chemical raw materials, chemical preparations, sales of chemical raw materials, chemical preparations, Chinese patent medicines, Chinese herbal medicines, biological products, medical devices, health food, food, beverages, special labor protection products, production and sales … Read more